These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 24402111)

  • 1. [Clinical protocol and therapeutic guidelines for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease].
    Custódio MR; Canziani ME; Moysés RM; Barreto FC; Neves CL; de Oliveira RB; Karohl C; Sampaio Ede A; Gueiros JE; Jorgetti V; de Carvalho AB
    J Bras Nefrol; 2013; 35(4):308-22. PubMed ID: 24402111
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevention and treatment of secondary hyperparathyroidism in CKD].
    Gueiros JE; Hernandes FR; Karohl C; Jorgetti V;
    J Bras Nefrol; 2011 Apr; 33 Suppl 1():7-14. PubMed ID: 21655856
    [No Abstract]   [Full Text] [Related]  

  • 3. [Programmed approach to the treatment of secondary hyperparathyroidism in chronic renal disease].
    Samokhvalov NA; Maĭstrenko NA; Romashchenko PN
    Vestn Khir Im I I Grek; 2013; 172(2):43-6. PubMed ID: 24000678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Guidelines on bone mineral disorder in chronic kidney disease--addendum chapter 2].
    Carvalho AB; Gueiros AP; Gueiros JE; Neves CL; Karohl C; Sampaio E; Canziani ME; Custódio MR; Moysés RM; Barreto F; Jorgetti V
    J Bras Nefrol; 2012 Jun; 34(2):199-205. PubMed ID: 22850924
    [No Abstract]   [Full Text] [Related]  

  • 5. Outpatient management of chronic kidney disease: proteinuria, anemia and bone disease as therapeutic targets.
    Lam A; Shah S; Paparello J
    Dis Mon; 2010 Apr; 56(4):215-32. PubMed ID: 20350654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reviewing the Brazilian protocol for treatment of secondary hyperparathyroidism.
    Romão JE
    J Bras Nefrol; 2013; 35(4):250-1. PubMed ID: 24402103
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hyperparathyroidism in patients on long-term hemodialysis].
    Rodosskaia NK; Orlova II; Brazhnikova VV
    Klin Med (Mosk); 2009; 87(4):68-70. PubMed ID: 19514326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Japanese Society of Dialysis Therapy treatment guidelines for secondary hyperparathyroidism.
    Kazama JJ
    Ther Apher Dial; 2007 Oct; 11 Suppl 1():S44-7. PubMed ID: 17976085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diuretics and secondary hyperparathyroidism in chronic kidney disease.
    Kovesdy CP; Kalantar-Zadeh K
    Nephrol Dial Transplant; 2011 Apr; 26(4):1122-5. PubMed ID: 21460359
    [No Abstract]   [Full Text] [Related]  

  • 10. Challenges in the therapy of secondary hyperparathyroidism.
    Wood C; González EA; Martin KJ
    Ther Apher Dial; 2005 Feb; 9(1):4-8. PubMed ID: 15828898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Outlines of K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease].
    Orita H; Akizawa T
    Clin Calcium; 2004 May; 14(5):693-7. PubMed ID: 15577029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of surgery in the treatment of renal secondary hyperparathyroidism.
    Schneider R; Bartsch DK
    Br J Surg; 2015 Mar; 102(4):289-90. PubMed ID: 25359005
    [No Abstract]   [Full Text] [Related]  

  • 13. Secondary and Tertiary Hyperparathyroidism.
    Messa P; Alfieri CM
    Front Horm Res; 2019; 51():91-108. PubMed ID: 30641516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Secondary and tertiary hyperparathyroidism and chronic renal insufficiency].
    Sebert JL; Fournier A; Leroux JL; Bedrossian J; Idatte JM; Guéris J; Kuntz D
    Acquis Med Recent; 1978; ():85-95. PubMed ID: 757745
    [No Abstract]   [Full Text] [Related]  

  • 15. Paricalcitol in secondary hyperparathyroidism and the survival benefit in patients with chronic kidney disease.
    Al-Baaj F; Yadav P; Al-Rifai A
    J Ren Care; 2011 Jun; 37(2):75-9. PubMed ID: 21561542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recurring secondary hyperparathyroidism: case report].
    Rozhinskaia LIa; Smorshchok VN; Artemova AM; Rodina LF; Makanin MA; Lapshina AM; Abrosimov AIu
    Klin Med (Mosk); 2009; 87(7):67-70. PubMed ID: 19705798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The D-lemia for preventing secondary hyperparathyroidism in chronic kidney disease.
    Holick MF
    Endocr Pract; 2008; 14(1):6-9. PubMed ID: 18238735
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical practice guideline for the management of secondary hyperparathyroidism in chronic dialysis patients.
    Guideline Working Group, Japanese Society for Dialysis Therapy
    Ther Apher Dial; 2008 Dec; 12(6):514-25. PubMed ID: 19140852
    [No Abstract]   [Full Text] [Related]  

  • 19. The new treatments of hyperparathyroidism secondary to renal insufficiency.
    Fournier A; Drüeke T; Morinière P; Zingraff J; Boudailliez B; Achard JM
    Adv Nephrol Necker Hosp; 1992; 21():237-306. PubMed ID: 1566648
    [No Abstract]   [Full Text] [Related]  

  • 20. Secondary and tertiary hyperparathyroidism.
    Jamal SA; Miller PD
    J Clin Densitom; 2013; 16(1):64-8. PubMed ID: 23267748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.